Last reviewed · How we verify

NCT05794594

3D Printed Personalized Extendable Prosthesis

Completed Last updated 3 April 2023
What this trial tests

trial testing 3D printed personalized extendable prosthesis in Osteosarcoma in Children in 25 participants. Completed in 1 March 2023.

Timeline
1 October 2015
Primary endpoint
1 January 2023
1 March 2023

Quick facts

Lead sponsorYuxi Su
StatusCompleted
Study typeOBSERVATIONAL
Enrollment25
Start date1 October 2015
Primary completion1 January 2023
Estimated completion1 March 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Yuxi Su

Who can join

Adults 6 to 18, any sex, with Osteosarcoma in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this type of observational study is to investigate the preliminary effect of 3D printed personalized extendable prosthesis replacement on limb salvage in children with osteosarcoma. The main question it aims to answer is: Is 3D printed personalized extendable prosthesis replacement has a good outcome in limb salvage pediatric osteosarcoma?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Yuxi Su trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05794594.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing